fexofenadine has been researched along with chitosan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, P; Cho, HJ; Chung, SJ; Hong, SS; Jang, TY; Kim, DD; Kim, KS; Park, EK; Shim, CK; Song, KW | 1 |
| Han, HK; Lee, BJ; Qiang, F; Shin, HJ | 1 |
| El-Ridi, MS; El-Sherif, NG; Tadros, MI; Yehia, SA | 1 |
| Srinivas, NR | 1 |
4 other study(ies) available for fexofenadine and chitosan
| Article | Year |
|---|---|
Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Intranasal; Animals; beta-Cyclodextrins; Cell Membrane Permeability; Cells, Cultured; Chitosan; Gels; Histamine H1 Antagonists, Non-Sedating; Humans; Poloxamer; Rabbits; Temperature; Terfenadine; Viscosity | 2011 |
Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Topics: Adhesiveness; Administration, Intranasal; Administration, Oral; Adsorption; Animals; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Cholesterol; Delayed-Action Preparations; Dimyristoylphosphatidylcholine; Drug Compounding; Histamine H1 Antagonists, Non-Sedating; Injections, Intravenous; Lipids; Liposomes; Male; Mucins; Nanoparticles; Particle Size; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Surface Properties; Technology, Pharmaceutical; Terfenadine | 2012 |
Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers.
Topics: Administration, Oral; Adult; Alginates; Anti-Allergic Agents; Chitosan; Excipients; Glucuronic Acid; Hexuronic Acids; Humans; Male; Phenylalanine; Tablets; Taste; Taste Perception; Terfenadine; Young Adult | 2015 |
The Interesting Case of Acyclovir Delivered Using Chitosan in Humans: Is it a Drug Issue or Formulation Issue?
Topics: Acyclovir; Adhesiveness; Administration, Oral; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Excipients; Humans; Intestinal Absorption; Permeability; Terfenadine | 2016 |